Pure Global AI
NCT06352515Not yet recruiting

T Lymphocyte Subsets in Ulcerative Colitis

Peripheral Blood T Lymphocyte Subsets in Ulcerative Colitis
Assiut UniversityClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Ulcerative Colitis
Drug/Device/Intervention
Flow cytometry
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 01, 2027
Enrollment
80 participants
Primary outcome

Study the distribution of T-cell subsets among ulcerative colitis patients.,Correlation of T-cell subtypes to therapeutic response

Summary

1. Study the distribution of peripheral blood T lymphocyte subsets among ulcerative colitis
 patients.
 
 2. Correlation of T-cell subsets to therapeutic response/ disease activity.
 
 3. Assess the value of circulating IgG anti-Integrin αvβ6 in UC.

ICD-10 classifications
Ulcerative colitisOther ulcerative colitisUlcerative colitis, unspecifiedArthropathy in ulcerative colitisJuvenile arthritis in ulcerative colitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06352515
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06352515 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Ulcerative Colitis. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.